Inflammation markers calculated from routine blood tests, such as ratios of different types of immune cells and a combined inflammation…
Articles by Margarida Maia, PhD
More than one-third of patients with newly diagnosed eosinophilic granulomatosis with polyangiitis (EGPA) already have serious heart disease,…
Risk factors for relapse in ANCA-associated vasculitis (AAV) appear to differ depending on treatment phase, with higher levels of…
Small particles loaded with manganese, an essential trace mineral, may help protect the kidneys from damage related to ANCA-associated…
Measuring immune cells called eosinophils can help predict the presence and severity of peripheral neuropathy (damage to nerves outside the…
Using both traditional and data-driven ways of grouping patients may give a clearer, more accurate picture of how different types…
Most people who test positive for ANCAs — the self-reactive antibodies that drive most ANCA-associated vasculitis (AAV) cases —…
Tavneos (avacopan) can control ANCA-associated vasculitis (AAV) just about as well as standard glucocorticoids but causes fewer side…
In severe ANCA-associated vasculitis (AAV), rituximab may be superior to cyclophosphamide at helping people survive beyond 10 years…
An increase in blood levels of a self-reactive antibody called MPO-ANCA predicted the return of ANCA-associated vasculitis (AAV) symptoms…